Since the human body is so complex, not all people will process insulin the same way. Factors like time of day, stress levels, and physical activity can make these numbers more difficult to predict.

On Wednesday, the FDA issued a Complete Response Letter (CRL) related to Novo Nordisk A/S’s (NYSE:NVO) Biologics License Application for once-weekly basal insulin icodec for diabetes mellitus.

Plus, insulin sensitivity is a complicated process, and taking a supplement alone is unlikely to make a huge difference in your blood sugar and weight, adds integrative and functional medicine ...

Announcing a new publication for Acta Materia Medica journal. The prevalence of diabetes is increasing and expected to become ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Deubiquitinating Enzymes Regulate Skeletal Muscle Mitochondrial Quality Control and Insulin Sensitivity in Patients With Type 2 Diabetes. Journal of Cachexia, Sarcopenia and Muscle , 2025; 16 (2 ...